What is it about?
Preclinical study of a novel therapy to treat patients battling Huntington's disease.
Featured Image
Why is it important?
If successful, this could be the first viable therapy to halt the progression of Huntington's disease.
Perspectives
This is a very interesting approach that combines gene and cell-based therapies to treat a patient population without any viable treatment options to halt disease progression.
Dr Johnathon D Anderson
University of California Davis
Read the Original
This page is a summary of: Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington’s Disease Mouse Models, Molecular Therapy, January 2016, Nature,
DOI: 10.1038/mt.2016.12.
You can read the full text:
Contributors
The following have contributed to this page
